Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The ursodeoxycholic acid story in primary biliary cirrhosis.

× No keyword cloud information.

49 in total

1. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

Authors: J Ludwig; E R Dickson; G S McDonald
Journal: Virchows Arch A Pathol Anat Histol Date: 1978-08-22

2. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.

Authors: Y Calmus; P Gane; P Rouger; R Poupon
Journal: Hepatology Date: 1990-01 Impact factor: 17.425

3. Ursodeoxycholic acid for primary biliary cirrhosis.

Authors: A F Hofmann; H Popper
Journal: Lancet Date: 1987-08-15 Impact factor: 79.321

4. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport.

Authors: M Dumont; S Erlinger; S Uchman
Journal: Gastroenterology Date: 1980-07 Impact factor: 22.682

5. Prognosis in primary biliary cirrhosis: model for decision making.

Authors: E R Dickson; P M Grambsch; T R Fleming; L D Fisher; A Langworthy
Journal: Hepatology Date: 1989-07 Impact factor: 17.425

6. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat.

Authors: K Kitani; M Ohta; S Kanai
Journal: Am J Physiol Date: 1985-04

7. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.

Authors: A Stiehl; R Raedsch; G Rudolph
Journal: Gastroenterology Date: 1990-02 Impact factor: 22.682

8. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors: R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal: Lancet Date: 1987-04-11 Impact factor: 79.321

9. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.

Authors: U Leuschner; M Leuschner; J Sieratzki; W Kurtz; K Hübner
Journal: Dig Dis Sci Date: 1985-07 Impact factor: 3.199

10. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.

Authors: J Van de Water; J Turchany; P S Leung; J Lake; S Munoz; C D Surh; R Coppel; A Ansari; Y Nakanuma; M E Gershwin
Journal: J Clin Invest Date: 1993-06 Impact factor: 14.808

3 in total

1. Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Authors: G Mazzella; P Fusaroli; A Pezzoli; F Azzaroli; C Mazzeo; L Zambonin; P Simoni; D Festi; E Roda
Journal: Dig Dis Sci Date: 1999-12 Impact factor: 3.199

2. Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.

Authors: Meri Koulentaki; Joanna Moscandrea; Philipos Dimoulios; Costas Chatzicostas; Elias A Kouroumalis
Journal: Dig Dis Sci Date: 2004-08 Impact factor: 3.199

3. Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.

Authors: M C Bateson; P Gedling
Journal: Postgrad Med J Date: 1998-08 Impact factor: 2.401

3 in total